Success Metrics

Clinical Success Rate
76.2%

Based on 64 completed trials

Completion Rate
76%(64/84)
Active Trials
6(6%)
Results Posted
56%(36 trials)
Terminated
20(19%)

Phase Distribution

Ph phase_4
24
22%
Ph early_phase_1
3
3%
Ph phase_1
14
13%
Ph phase_3
20
19%
Ph not_applicable
16
15%
Ph phase_2
29
27%

Phase Distribution

17

Early Stage

29

Mid Stage

44

Late Stage

Phase Distribution106 total trials
Early Phase 1First-in-human
3(2.8%)
Phase 1Safety & dosage
14(13.2%)
Phase 2Efficacy & side effects
29(27.4%)
Phase 3Large-scale testing
20(18.9%)
Phase 4Post-market surveillance
24(22.6%)
N/ANon-phased studies
16(15.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

74.4%

64 of 86 finished

Non-Completion Rate

25.6%

22 ended early

Currently Active

6

trials recruiting

Total Trials

107

all time

Status Distribution
Active(8)
Completed(64)
Terminated(22)
Other(13)

Detailed Status

Completed64
Terminated20
unknown13
Recruiting4
Not yet recruiting2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
107
Active
6
Success Rate
76.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (2.8%)
Phase 114 (13.2%)
Phase 229 (27.4%)
Phase 320 (18.9%)
Phase 424 (22.6%)
N/A16 (15.1%)

Trials by Status

not_yet_recruiting22%
unknown1312%
recruiting44%
active_not_recruiting22%
terminated2019%
withdrawn22%
completed6460%

Recent Activity

Clinical Trials (107)

Showing 20 of 107 trialsScroll for more
NCT05304273Phase 3

Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages

Completed
NCT05322252Phase 4

Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial

Completed
NCT06099769Phase 2

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Recruiting
NCT03225547Phase 2

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Terminated
NCT05177510Phase 2

Mifepristone Outpatient Labour Induction

Recruiting
NCT06502158Phase 1

Mifepristone vs Misoprostol

Recruiting
NCT02788981Phase 2

Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

Active Not Recruiting
NCT02989662Phase 1

INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers

Completed
NCT04254627Phase 1

TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset

Active Not Recruiting
NCT05341817Phase 4

The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy

Recruiting
NCT06733727Not Applicable

Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage

Not Yet Recruiting
NCT05217758Phase 2

RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma

Completed
NCT03913104Phase 4

Mail Order Mifepristone Study

Completed
NCT05097326Phase 3

Mifepristone for Labor Induction

Completed
NCT06492889Phase 2

Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens

Not Yet Recruiting
NCT01294319Phase 2

Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men

Completed
NCT01862991Not Applicable

Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services

Completed
NCT01615731Not Applicable

Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks

Completed
NCT00383032Not Applicable

Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction

Completed
NCT00133705Phase 3

Trial of Mifepristone for Fibroids

Completed

Drug Details

Intervention Type
DRUG
Total Trials
107